Home » Topics » Regulatory » Patents

Patents
RSS

Qilu Regor Therapeutics patents MALT1 inhibitors

Jan. 25, 2021

BioWorld MedTech Patent Highlights: Week 2

From Current Patent Gazette

Jan. 22, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

UCB describes new dopamine D1 receptor PAMs

Jan. 22, 2021

New chymase inhibitors patented by Medshine Discovery

Jan. 22, 2021

New STING modulators identified at Camphor Pharmaceuticals

Jan. 22, 2021

Sunshine Lake Pharma discovers ACC1/ACC2 inhibitors

Jan. 22, 2021

Codiak Biosciences describes extracellular vesicles targeting T cells

Jan. 22, 2021

Tavotek Biotherapeutics presents bispecific antibodies to TNF-alpha, IL-1beta

Jan. 21, 2021

Merck & Co. discovers antituberculosis compounds

Jan. 21, 2021

New cannabinoid CB1/CB2 receptor ligands presented by Canopy Growth Corp.

Jan. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...